Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of genetically engineered bacterium of attenuated Salmonella typhimurium in for treating liver cancer

Use of genetically engineered bacterium of attenuated Salmonella typhimurium in for treating liver cancer

US Patent 11318172 · Granted May 3, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of genetically engineered strain VNP20009-M in preventing and treating cance2025
Use of genetically engineered strain VNP20009-M in preventing and treating cance2025
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Applications of genetically engineered bacteria VNP20009-M in preparation of dru2023
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of genetically engineered bacteria VNP20009-M in preparing drug for 2022
Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of medicatio2021
Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of medicatio2021